Novel Use Of Dupilumab In A Patient With Post-Acute Sequelae of SARS-CoV-2 Infection With Severe Persistent Asthma

Detalles Bibliográficos
Autores principales: Ashraf, Anam, Eslam, Mohamed, Lam, Weyman, Avila, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Mosby, Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804461/
http://dx.doi.org/10.1016/j.jaci.2021.12.603
_version_ 1784643076267966464
author Ashraf, Anam
Eslam, Mohamed
Lam, Weyman
Avila, Andrew
author_facet Ashraf, Anam
Eslam, Mohamed
Lam, Weyman
Avila, Andrew
author_sort Ashraf, Anam
collection PubMed
description
format Online
Article
Text
id pubmed-8804461
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Mosby, Inc.
record_format MEDLINE/PubMed
spelling pubmed-88044612022-02-01 Novel Use Of Dupilumab In A Patient With Post-Acute Sequelae of SARS-CoV-2 Infection With Severe Persistent Asthma Ashraf, Anam Eslam, Mohamed Lam, Weyman Avila, Andrew J Allergy Clin Immunol Article Published by Mosby, Inc. 2022-02 2022-02-01 /pmc/articles/PMC8804461/ http://dx.doi.org/10.1016/j.jaci.2021.12.603 Text en Copyright © 2021 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Ashraf, Anam
Eslam, Mohamed
Lam, Weyman
Avila, Andrew
Novel Use Of Dupilumab In A Patient With Post-Acute Sequelae of SARS-CoV-2 Infection With Severe Persistent Asthma
title Novel Use Of Dupilumab In A Patient With Post-Acute Sequelae of SARS-CoV-2 Infection With Severe Persistent Asthma
title_full Novel Use Of Dupilumab In A Patient With Post-Acute Sequelae of SARS-CoV-2 Infection With Severe Persistent Asthma
title_fullStr Novel Use Of Dupilumab In A Patient With Post-Acute Sequelae of SARS-CoV-2 Infection With Severe Persistent Asthma
title_full_unstemmed Novel Use Of Dupilumab In A Patient With Post-Acute Sequelae of SARS-CoV-2 Infection With Severe Persistent Asthma
title_short Novel Use Of Dupilumab In A Patient With Post-Acute Sequelae of SARS-CoV-2 Infection With Severe Persistent Asthma
title_sort novel use of dupilumab in a patient with post-acute sequelae of sars-cov-2 infection with severe persistent asthma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804461/
http://dx.doi.org/10.1016/j.jaci.2021.12.603
work_keys_str_mv AT ashrafanam noveluseofdupilumabinapatientwithpostacutesequelaeofsarscov2infectionwithseverepersistentasthma
AT eslammohamed noveluseofdupilumabinapatientwithpostacutesequelaeofsarscov2infectionwithseverepersistentasthma
AT lamweyman noveluseofdupilumabinapatientwithpostacutesequelaeofsarscov2infectionwithseverepersistentasthma
AT avilaandrew noveluseofdupilumabinapatientwithpostacutesequelaeofsarscov2infectionwithseverepersistentasthma

Ejemplares similares